This document is a patent application (US20260085304A1) filed with the USPTO, describing a novel method for purifying and isolating collagenase compositions. The invention focuses on enhancing the purity and stability of collagenase I and collagenase II, aiming for compositions that are at least 95% pure by area via RP-HPLC and are essentially free of neutral protease.

As this is a patent application, it does not impose immediate regulatory obligations on entities. However, companies involved in the research, development, or manufacturing of collagenase-based products, particularly in the pharmaceutical and biotechnology sectors, should be aware of this potential intellectual property. Monitoring the progress of this patent application and similar innovations is advisable for competitive intelligence and potential licensing opportunities.